A Learning Center on Guidelines to Practice | US and Global Perspectives | Patient Resources
NCCN Clinician and Patient resources
TRANSLATED TRANSCRIPTS
-
Why ICIs Have Revolutionized Cancer Care
-
Advances in the Care of Patients with MSI-H/dMMR or HER2+ Colorectal Cancers
-
Immune-Based Advances in Gastric, Esophageal, and Gastroesophageal Junction Cancers
-
Optimizing Care for Patients with Advanced Hepatocellular Carcinoma: Current Standards and Future Directions with Immunotherapy
-
Establishing the Role of Immunotherapy in Microsatellite Instability-High (MSI-H) or Mismatch Repair-Deficient (dMMR) Endometrial Cancer
-
Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
-
The Current and Future Role of Immuno-Oncologic Agents in Early-Stage, Locally Advanced, and Metastatic NSCLC
-
Utilization and Management of Antibody-Drug Conjugates in Metastatic Breast Cancer: The Relationship Between ADCs and HER2
-
Current Standards and Future Opportunities for ADCs in Advanced/Metastatic Triple-Negative Breast Cancer
-
Current and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
-
Selecting and Sequencing Immunotherapies for Patients with Advanced RCC